French research rallies to the cause In the face of malaria, a plague that is likely to affect more than 2 billion people in around one hundred countries in the South, mobilisation of the international community has increased significantly in recent years. Through its financial commitments, its actions in the field, and its research and training programmes, France has confirmed itself as a key player in this international mobilisation against malaria. Multilateral cooperation In order to provide support for the most vulnerable populations, France has opted for multilateral cooperation, particularly through signiﬁcant participation in the Global Fund to Fight AIDS, Tuberculosis and Malaria. This ﬁnancial arrangement contributes 60% of world funding for the ﬁght against malaria. To date, France is the primary European contributor to this Global Fund, and is its second biggest donor, after the United States. France has also associated with other international initiatives against malaria, such as the “Roll Back Malaria” programme headed by the WHO, or through ﬁnancing UNITAID or DNDi (Drug for neglected diseases initiatives), programmes that make it easier to provide treatment for the most poverty-stricken populations. Many French NGO participate very actively in the ﬁeld as part of the mobilisation against this disease. Distributing mosquito nets. Deeply committed research For many years, a large number of French research teams have been mobilised against malaria in laboratories and in the ﬁeld, particularly at the Pasteur Institute and the IRD, as well as at Inserm, the CNRS, several universities and the Military Health Department. Their programmes, which are supported by the French State Departments for Foreign and European Affairs, and Research, have been implemented in close collaboration with the national research organisations in the countries in the South. They include actions to train and support scientiﬁc teams in these countries, as a means of reinforcing their ability to conduct research into malaria. In France, particularly with sanoﬁ-aventis’ “Impact Malaria” initiative, the pharmaceutics industry is now a stakeholder in these efforts through a variety of actions: researching new anti-malarial compounds, making treatments available at cost price for public health services, developing tools for training medical personnel and raising awareness in the communities. France contributes 16% of international funding, thus making it the world’s second biggest contributor to the ﬁght against malaria. Preparing mosquitoes for analysis in laboratories. The ﬁght goes on… In the last decade, signiﬁcant progress has been made. Today, malaria can be avoided, diagnosed and treated thanks to a combination of means: mosquito nets impregnated with insecticides, high performance diagnosis tools, effective treatments against resistance, and so on, without forgetting the information campaigns targeted at the populations concerned. However, to attain the Millenium Objective for 2015 of controlling the disease, as envisaged by the international community, the mobilisation of all the key players, in the South and in the North, must, more than ever, continue. Manufacturing impregnated mosquito nets in Tanzania.